Suppressor effect of catechol-O-methyltransferase gene in prostate cancer.
Catechol-estrogens can cause genetic mutations and to counteract their oncogenicity, the catechol-O-methyltransferase (COMT) gene is capable of neutralizing these reactive compounds. In this study, we determined the functional effects and regulation of COMT in prostate cancer. Both the Cancer Genome...
Guardado en:
Autores principales: | Yutaka Hashimoto, Marisa Shiina, Shigekatsu Maekawa, Taku Kato, Varahram Shahryari, Priyanka Kulkarni, Pritha Dasgupta, Soichiro Yamamura, Sharanjot Saini, Z Laura Tabatabai, Rajvir Dahiya, Yuichiro Tanaka |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/76ee1a5071504b8785c7c337d3e5510a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Genistein up-regulates tumor suppressor microRNA-574-3p in prostate cancer.
por: Takeshi Chiyomaru, et al.
Publicado: (2013) -
Deficiency in catechol-o-methyltransferase is linked to a disruption of glucose homeostasis in mice
por: Megumi Kanasaki, et al.
Publicado: (2017) -
Depression and Catechol-O-methyltransferase (COMT) genetic variants are associated with pain in Parkinson’s disease
por: Chin-Hsien Lin, et al.
Publicado: (2017) -
The relationship between the val158met catechol-O-methyltransferase (COMT) polymorphism and irritable bowel syndrome.
por: Pontus Karling, et al.
Publicado: (2011) -
Catechol-O-methyltransferase (COMT) protein expression and activity after dopaminergic and noradrenergic lesions of the rat brain.
por: Nadia Schendzielorz, et al.
Publicado: (2013)